Author avatar

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2024-09-25 12:44:41

Major Microbial Associations (MMAs)

Major Microbial Associations (MAs) are fundamental in understanding disease-microbiome interactions and play a crucial role in advancing microbiome-targeted interventions aimed at treating or preventing diseases through microbial modulation.

2024-09-24 12:28:53

Gram-Negative Bacteria

Gram-negative bacteria are resilient pathogens with antibiotic resistance, causing infections like TIs, sepsis, and pneumonia.

2024-09-24 10:20:32

Oxidase Positive

Oxidase positivity in an organism refers to the ability of the organism to produce the enzyme cytochrome c oxidase, which is involved in the electron transport chain during aerobic respiration.

2024-09-18 11:43:23

Koch’s Postulates

Overview Koch’s postulates, formulated by Robert Koch in the late 19th century, were a set of criteria used to establish a causative relationship between a specific microbe and a disease. These postulates became foundational in microbiology, providing a systematic approach for identifying pathogenic microorganisms. The original postulates consist of four criteria:Presence of the Microbe in […]

2024-08-10 16:34:51

The gut microbiota–brain axis in neurological disorder

What was reviewed?The review paper provides a comprehensive overview of the gut microbiota-brain axis (BA) and its role in various neurological disorders. Specifically, the paper examined the intricate bidirectional communication between the gut microbiota (M) and the central nervous system (NS), exploring how dysbiosis (an imbalance in the gut microbiota) contributes to the pathogenesis of […]

2024-08-10 11:11:03

Neuromicrobiology, an Emerging Neurometabolic Facet of the Gut Microbiome?

What Was The paper reviews the emerging field of neuromicrobiology, which explores the interactions between the gut microbiome and the brain, particularly focusing on how gut microbiota produce neuroactive metabolites that influence cognitive function and brain health. It addresses the biosynthesis, absorption, and transport of these neuroactive metabolites, including neurotransmitters such as γ-aminobutyric acid (ABA), […]